Search results
Oct 28, 2020 · While the federal government funded the Human Genome Project, there was a parallel effort in the private sector led by Craig Venter at Celera Genomics, followed by a proliferation of new...
- Katie Jennings
- Keith Speights
- Illumina. Since its 1998 founding, Illumina has become an industry leader with more than 90% of the global sequencing market and an installed base of more than 17,000 sequencing systems.
- Pacific Biosciences of California. Pacific Biosciences of California (also known as PacBio) is pioneering long-read sequencing technology, which uses longer DNA segments to map the whole genome.
- 10x Genomics. 10x was founded in 2012 to “build solutions for scientific discovery that reveal and address the true complexities of biology and disease.”
- Bionano Genomics. Bionano was founded in 2003 with a mission “committed to the relentless pursuit of the truth in genomics.” The company is using its optical genome mapping technology to perform structural variant detection for cancer research and precision medicine.
- Sarepta Therapeutics, Inc. (NASDAQ:SRPT) No of HFs: 35. Total Value of HF Holdings: $880 Million. SRPT ranks 6th in our list of the best genomic stocks to buy now.
- Blueprint Medicines Corp (NASDAQ:BPMC) No of HFs: 34. Total Value of HF Holdings: $1.2 Billion. BPMC ranks 7th in our list of the best genomic stocks to buy now.
- Qiagen NV (NYSE:QGEN) No of HFs: 29. Total Value of HF Holdings: $580 Million. Qiagen NV is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
- Crispr Therapeutics AG (NASDAQ:CRSP) No of HFs: 26. Total Value of HF Holdings: $405 Million. CRSP ranks 9th in our list of the best genomic stocks to buy now.
John Craig Venter (born October 14, 1946) is an American biotechnologist and businessman. He is known for leading one of the first draft sequences of the human genome and assembled the first team to transfect a cell with a synthetic chromosome.
Apr 4, 2024 · Investing in Genetic Testing Stocks. By Steve Ditto – Updated Apr 4, 2024 at 12:55PM. Key Points. Human Genome Project's completion in 2003 revolutionized genetic testing, enabling medical...
Sep 18, 2023 · 18 September 2023. Geneticist J. Craig Venter: ‘I consider retirement tantamount to death’. The human genome ‘maverick’ talks sequencing the ocean, setting up a health-screening company...
People also ask
Who is Craig Venter?
Who funded the Human Genome Project?
Are gene sequencing stocks a good investment?
Did Craig Venter create life in a lab using DNA?
Armed with the latest sequencing technology developed by Applied Biosystems, Venter co-founded Celera Genomics in 1998, a commercial company embarking on the landmark scientific quest to sequence and analyze the human genome. Two years after sequencing the model organism the fruit fly as a test project, President Bill Clinton announced the ...
